How Medicare Negotiated Drug Prices Compare to Other Countries
(By Delaney Tevis, Matt McGough, Juliette Cubanski, and Cynthia Cox for The Kaiser Family Foundation Published: Dec 19, 2024) This
Read More
Medicare Part D
How a Duty To Spend Wisely on Worker Benefits Could Loosen PBMs’ Grip on Drug Prices
(By Arthur Allen for KFF Health News) Ann Lewandowski knows all about pharmacy benefit managers, or PBMs, the companies that
Read MoreHRSA warns Sanofi over 340B rebate proposal
(By Alexandra Murphy for Becker’s Hospital Review) The Health Resources and Services Administration has issued a warning to Sanofi over
Read More5 Medicare Advantage changes coming in 2025
(By Rylee Wilson for Becker’s Hospital Review) Medicare Advantage plans must comply with new network adequacy and health equity standards
Read MoreFTC sends warning to 21 insurance marketing companies
(By Jakob Emerson for Becker’s Hospital Review) The Federal Trade Commission has sent warning letters to 21 companies marketing or
Read MoreOutpatient pharmacy costs outpace total spend by 52%
(By Paige Twenter for Becker’s Hospital Review) Historically viewed as cost centers, hospitals and health systems are increasingly identifying their
Read MoreMedicare costs are going up next year
Like most things, Medicare costs are going up next year. Medicare Part A and Part B deductibles will increase, along
Read MoreMedicare Spending was 27% More for People who Disenrolled from Medicare Advantage than for Similar People in Traditional Medicare
(By Jeannie Fuglesten Biniek, Alex Cottrill, Nolan Sroczynski, and Tricia Neuman for The Kaiser Family Foundation Published: Dec 06, 2024)
Read MoreBiden-Harris Administration Announces Medicare Advantage and Medicare Part D Prescription Drug Proposals that Aim to Improve Care and Access for Enrollees
Press Release from hhs.gov on November 26, 2024 Today, the Centers for Medicare & Medicaid Services (CMS) is proposing actions
Read MoreOzempic, Wegovy covered by Medicare and Medicaid under Biden admin proposal for anti-obesity GLP-1 drugs
By Greg Norman for Fox News on November 26, 2024 The Biden administration is expanding coverage of anti-obesity drugs such as Ozempic
Read More